Literature DB >> 10024364

Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell.

A L Svingos1, E E Colago, V M Pickel.   

Abstract

The nucleus accumbens (Acb) is prominently involved in the aversive behavioral aspects of kappa-opioid receptor (KOR) agonists, including its endogenous ligand dynorphin (Dyn). We examined the ultrastructural immunoperoxidase localization of KOR and immunogold labeling of Dyn to determine the major cellular sites for KOR activation in this region. Of 851 KOR-labeled structures sampled from a total area of 10,457 microm2, 63% were small axons and morphologically heterogenous axon terminals, 31% of which apposed Dyn-labeled terminals or also contained Dyn. Sixty-eight percent of the KOR-containing axon terminals formed punctate-symmetric or appositional contacts with unlabeled dendrites and spines, many of which received convergent input from terminals that formed asymmetric synapses. Excitatory-type terminals that formed asymmetric synapses with dendritic spines comprised 21% of the KOR-immunoreactive profiles. Dendritic spines within the neuropil were the major nonaxonal structures that contained KOR immunoreactivity. These spines also received excitatory-type synapses from unlabeled terminals and were apposed by Dyn-containing terminals. These results provide ultrastructural evidence that in the Acb shell (AcbSh), KOR agonists play a primary role in regulating the presynaptic release of Dyn and other neuromodulators that influence the output of spiny neurons via changes in the presynaptic release of or the postsynaptic responses to excitatory amino acids. The cellular distribution of KOR complements those described previously for the reward-associated mu- and delta-opioid receptors in the Acb shell.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024364      PMCID: PMC6782165     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  74 in total

1.  Biochemical properties and subcellular distribution of an N-type calcium channel alpha 1 subunit.

Authors:  R E Westenbroek; J W Hell; C Warner; S J Dubel; T P Snutch; W A Catterall
Journal:  Neuron       Date:  1992-12       Impact factor: 17.173

2.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.

Authors:  R Spanagel; A Herz; T S Shippenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

3.  Opioids at low concentration decrease openings of K+ channels in sensory ganglion neurons.

Authors:  S F Fan; K F Shen; S M Crain
Journal:  Brain Res       Date:  1991-08-30       Impact factor: 3.252

Review 4.  Exocytosis from neuronal large dense-cored vesicles.

Authors:  A K Thureson-Klein; R L Klein
Journal:  Int Rev Cytol       Date:  1990

5.  Dual ultrastructural localization of mu-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens.

Authors:  K N Gracy; A L Svingos; V M Pickel
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

6.  Kappa receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum.

Authors:  S M Rawls; J F McGinty
Journal:  J Neurochem       Date:  1998-02       Impact factor: 5.372

7.  Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.

Authors:  M H Heijna; M Padt; F Hogenboom; P S Portoghese; A H Mulder; A N Schoffelmeer
Journal:  Eur J Pharmacol       Date:  1990-06-08       Impact factor: 4.432

8.  Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.

Authors:  T S Shippenberg; R Bals-Kubik; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

9.  Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus.

Authors:  J J Wagner; R M Caudle; C Chavkin
Journal:  J Neurosci       Date:  1992-01       Impact factor: 6.167

10.  Blockade of morphine reward through the activation of kappa-opioid receptors in mice.

Authors:  M Funada; T Suzuki; M Narita; M Misawa; H Nagase
Journal:  Neuropharmacology       Date:  1993-12       Impact factor: 5.250

View more
  66 in total

1.  Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias.

Authors:  G E Meredith; I E De Souza; T M Hyde; G Tipper; M L Wong; M F Egan
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 2.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 3.  Pathobiology of dynorphins in trauma and disease.

Authors:  Kurt F Hauser; Jane V Aldrich; Kevin J Anderson; Georgy Bakalkin; MacDonald J Christie; Edward D Hall; Pamela E Knapp; Stephen W Scheff; Indrapal N Singh; Bryce Vissel; Amina S Woods; Tatiana Yakovleva; Toni S Shippenberg
Journal:  Front Biosci       Date:  2005-01-01

Review 4.  Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.

Authors:  William A Carlezon; Andrew D Krystal
Journal:  Depress Anxiety       Date:  2016-10       Impact factor: 6.505

5.  κ Opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake.

Authors:  Timothy W Whitfield; Joel E Schlosburg; Sunmee Wee; Adam Gould; Olivier George; Yanabel Grant; Eva R Zamora-Martinez; Scott Edwards; Elena Crawford; Leandro F Vendruscolo; George F Koob
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

6.  Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats.

Authors:  Shayla E Russell; Anna B Rachlin; Karen L Smith; John Muschamp; Loren Berry; Zhiyang Zhao; Elena H Chartoff
Journal:  Biol Psychiatry       Date:  2013-10-03       Impact factor: 13.382

7.  Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.

Authors:  Abigail G Schindler; Daniel I Messinger; Jeffrey S Smith; Haripriya Shankar; Richard M Gustin; Selena S Schattauer; Julia C Lemos; Nicholas W Chavkin; Catherine E Hagan; John F Neumaier; Charles Chavkin
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

8.  κ-Opioid receptors in the central amygdala regulate ethanol actions at presynaptic GABAergic sites.

Authors:  Maenghee Kang-Park; Brigitte L Kieffer; Amanda J Roberts; George R Siggins; Scott D Moore
Journal:  J Pharmacol Exp Ther       Date:  2013-04-15       Impact factor: 4.030

9.  Closing the gate in the limbic striatum: prefrontal suppression of hippocampal and thalamic inputs.

Authors:  Gwendolyn G Calhoon; Patricio O'Donnell
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

10.  Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system.

Authors:  Arati Kreibich; Beverly A S Reyes; Andre L Curtis; Laurel Ecke; Charles Chavkin; Elisabeth J Van Bockstaele; Rita J Valentino
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.